IP Library Granted Patent US 10,308,613
Granted Patent B2
US 10,308,613 · App. 15/314,999 · Granted Jun 4, 2019

Fluoroalkylating agent

Inventors: Kentaro Kawazoe (Tokyo, JP); Kotaro Yoshioka (Tokyo, JP)
Assignee: KUMIAI CHEMICAL INDUSTRY CO., LTD.
C07D235/10C07C29/38C07C31/38C07C67/343C07C319/14C07C319/20C07C323/12C07D213/30C07D333/16C07B61/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,308,613
App. No.
15/314,999
Granted
Jun 4, 2019
Kind
B2
Abstract

Problem to be Solved It is intended to provide an industrially preferable fluoroalkylating agent and use thereof. Solution The present invention provides a fluoroalkylating agent represented by the general formula (1) wherein R 1 is a C1 to C8 fluoroalkyl group; R 2 and R 3 are each independently a C1 to C12 alkyl group or the like; Y 1 to Y 4 are each independently a hydrogen atom, a halogen atom, or the like; and X − is a monovalent anion. A compound of the general formula (3): R 4 —S—R 1 having an introduced C1 to C8 fluoroalkyl group is easily obtained by reacting a compound of the general formula (2): R 4 —S—Z wherein R 4 is a hydrocarbon group or the like; and Z is a leaving group, with the compound of the general formula (1).

Claims (263)

1. A fluoroalkylating agent represented by the general formula (1):

wherein R 1 is a C1 to C8 fluoroalkyl group;

R 2 and R 3 are each independently

a C1 to C12 alkyl group which may have one or more substituents,

a C2 to C6 alkenyl group which may have one or more substituents,

a C2 to C6 alkynyl group which may have one or more substituents,

a C3 to C8 cycloalkyl group which may have one or more substituents, or

a C6 to C10 aryl group which may have one or more substituents;

Y 1 , Y 2 , Y 3 and Y 4 are each independently

a hydrogen atom, a halogen atom, a nitro group, a cyano group,

a C1 to C12 alkyl group which may have one or more substituents,

a C2 to C6 alkenyl group which may have one or more substituents,

a C2 to C6 alkynyl group which may have one or more substituents,

a C3 to C8 cycloalkyl group which may have one or more substituents,

a hydroxy group,

a C1 to C6 alkoxy group,

a C1 to C6 alkylthio group, a C1 to C6 alkylsulfinyl group, a C1 to C6 alkylsulfonyl group,

an amino group, a mono (C1 to C6 alkyl) amino group, a di (C1 to C6 alkyl) amino group,

a C1 to C6 acylamino group,

a formyl group, a C2 to C6 acyl group,

a C1 to C6 alkoxycarbonyl group,

a C6 to C10 aryl group which may have one or more substituents, or

a heterocyclic group which may have one or more substituents, wherein the said heterocyclic group is a 5- to 10-membered heterocyclic group having 1 to 9 carbon atoms and 1 to 4 heteroatoms selected independently from a nitrogen atom, an oxygen atom and a sulfur atom, or two adjacent substituents of Y 1 and Y 2 , Y 2 and Y 3 , or Y 3 and Y 4 , together with carbon atoms to which these substituents are attached, form a 4- to 8-membered carbocyclic ring or a 4- to 8-membered heterocyclic ring having 1 to 4 heteroatoms selected independently from an oxygen atom, a sulfur atom and a nitrogen atom, wherein the said formed ring may have one or more substituents; and

X − is a monovalent anion;

wherein, the one or more substituents in each case is independently selected from the group consisting of a halogen atom, a nitro group, a cyano group,

a C1 to C6 alkyl group,

a C2 to C6 alkenyl group,

a C2 to C6 alkynyl group,

a C3 to C8 cycloalkyl group,

a C1 to C6 haloalkyl group,

a hydroxy group,

a C1 to C6 alkoxy group,

a C1 to C6 haloalkoxy group,

a C1 to C6 alkylthio group, a C1 to C6 alkylsulfinyl group, a C1 to C6 alkylsulfonyl group,

a C1 to C6 haloalkylthio group, a C1 to C6 haloalkylsulfinyl group, a C1 to C6 haloalkylsulfonyl group,

an amino group, a mono (C1 to C6 alkyl) amino group, a di (C1 to C6 alkyl) amino group,

a C1 to C6 acylamino group,

a formyl group, a C2 to C6 acyl group,

a C1 to C6 alkoxycarbonyl group,

a mono (C1 to C6 alkyl) aminocarbonyl group, a di (C1 to C6 alkyl) aminocarbonyl group,

a C6 to C10 aryl group,

a C6 to C10 aryloxy group,

a C6 to C10 aryl C1 to C4 alkyl group, and

a heterocyclic group, wherein the heterocyclic group is a 5- to 10-membered heterocyclic group having 1 to 9 carbon atoms and 1 to 4 heteroatoms selected independently from a nitrogen atom,

an oxygen atom and a sulfur atom,

provided that the following cases of (i) to (x) are excluded:

(i) R 1 is a trifluoromethyl group,

R 2 and R 3 are each a methyl group,

Y 1 , Y 2 , Y 3 and Y 4 are each a hydrogen atom, and

X − is Br − ;

(ii) R 1 is a trifluoromethyl group,

R 2 and R 3 are each a methyl group,

Y 1 , Y 2 , Y 3 and Y 4 are each a hydrogen atom, and

X − is I − ;

(iii) R 1 is a trifluoromethyl group,

R 2 and R 3 are each a methyl group,

Y 1 is a hydrogen atom,

Y 2 is a methyl group,

Y 3 is a methyl group,

Y 4 is a hydrogen atom, and

X − is I − ;

(iv) R 1 is a trifluoromethyl group,

R 2 and R 3 are each a methyl group,

Y 1 is a hydrogen atom,

Y 2 is a chlorine atom,

Y 3 is a hydrogen atom,

Y 4 is a hydrogen atom, and

X − is Br − ;

(v) R 1 is a trifluoromethyl group,

R 2 and R 3 are each a methyl group,

Y 1 , Y 2 , Y 3 and Y 4 are each a bromine atom,

X − is Br −

(vi) R 1 is a trifluoromethyl group,

R 2 is a butyl group,

R 3 is a propyl substituted by a SO 3 H group,

Y 1 , Y 2 , Y 3 and Y 4 are each a hydrogen atom and

X − is H 2 PO 4 − ;

(vii) R 1 is a trifluoromethyl group,

R 2 is a butyl group,

R 3 is a propyl substituted by a SO 3 H group,

Y 1 , Y 2 , Y 3 and Y 4 are each a hydrogen atom and

X − is HSO 4 − ;

(viii) R 1 is a trifluoromethyl group,

R 2 is a butyl group,

R 3 is a propyl substituted by a SO 3 H group,

Y 1 , Y 2 , Y 3 and Y 4 are each a hydrogen atom and

X − is p-tosylate;

(ix) R 1 is a trifluoromethyl group,

R 2 is a methyl group,

R 3 is a CH═CH—COCF 3 ,

Y 1 , Y 2 , Y 3 and Y 4 are each a hydrogen atom and

X − is triflate, and

(x) R 1 is CH 2 F,

R 2 is a methyl group,

R 3 is an ethyl group,

Y 1 , Y 3 and Y 4 are each a hydrogen atom,

Y 2 is CF 3 and

X − is p-tosylate;

wherein, the one or more substituents in each case is independently selected from the group consisting of a halogen atom, a nitro group, a cyano group,

a C1 to C6 alkyl group,

a C2 to C6 alkenyl group,

a C2 to C6 alkynyl group,

a C3 to C8 cycloalkyl group,

a C1 to C6 haloalkyl group,

a hydroxy group,

a C1 to C6 alkoxy group,

a C1 to C6 haloalkoxy group,

a C1 to C6 alkylthio group, a C1 to C6 alkylsulfinyl group, a C1 to C6 alkylsulfonyl group,

a C1 to C6 haloalkylthio group, a C1 to C6 haloalkylsulfinyl group, a C1 to C6 haloalkylsulfonyl group,

an amino group, a mono (C1 to C6 alkyl) amino group, a di (C1 to C6 alkyl) amino group,

a C1 to C6 acylamino group,

a formyl group, a C2 to C6 acyl group,

a C1 to C6 alkoxycarbonyl group,

a mono (C1 to C6 alkyl) aminocarbonyl group, a di (C1 to C6 alkyl) aminocarbonyl group,

a C6 to C10 aryl group,

a C6 to C10 aryloxy group,

a C6 to C10 aryl C1 to C4 alkyl group, and

a heterocyclic group, wherein the heterocyclic group is a 5- to 10-membered heterocyclic group having 1 to 9 carbon atoms and 1 to 4 heteroatoms selected independently from a nitrogen atom,

an oxygen atom and a sulfur atom.

2. The agent according to claim 1 , wherein

R 1 is a C1 to C4 perfluoroalkyl group;

R 2 and R 3 are each independently a C1 to C4 alkyl group or a phenyl group;

Y 1 , Y 2 , Y 3 and Y 4 are each independently

a hydrogen atom, a halogen atom, a nitro group, a cyano group,

a C1 to C4 alkyl group or a C1 to C4 haloalkyl group; and

X − is Cl − , Br − , I − ,

BF 4 − ,

CF 3 SO 3 − ,

HOSO 3 − , CH 3 OSO 3 − or C 2 H 5 OSO 3 − .

3. The agent according to claim 1 , wherein

R 1 is a trifluoromethyl group or a pentafluoroethyl group;

R 2 and R 3 are each independently a methyl group, an ethyl group or a phenyl group;

Y 1 , Y 2 , Y 3 and Y 4 are each independently a hydrogen atom, a chlorine atom or a nitro group; and

X − is Cl − , Br − , I − ,

BF 4 − ,

CF 3 SO 3 − ,

HOSO 3 − , CH 3 OSO 3 − or C 2 H 5 OSO 3 − .

4. The agent according to claim 1 , wherein

R 1 is a trifluoromethyl group;

R 2 and R 3 are each a methyl group;

Y 1 , Y 2 , Y 3 and Y 4 are each a hydrogen atom; and

X − is CH 3 OSO 3 −.

5. A compound represented by the general formula (1A):

wherein R 1 is a C1 to C8 fluoroalkyl group;

R 2 and R 3 are each independently

a C1 to C12 alkyl group which may have one or more substituents,

a C2 to C6 alkenyl group which may have one or more substituents,

a C2 to C6 alkynyl group which may have one or more substituents,

a C3 to C8 cycloalkyl group which may have one or more substituents, or

a C6 to C10 aryl group which may have one or more substituents;

Y 1 , Y 2 , Y 3 and Y 4 are each independently

a hydrogen atom, a halogen atom, a nitro group, a cyano group,

a C1 to C12 alkyl group which may have one or more substituents,

a C2 to C6 alkenyl group which may have one or more substituents,

a C2 to C6 alkynyl group which may have one or more substituents,

a C3 to C8 cycloalkyl group which may have one or more substituents,

a hydroxy group,

a C1 to C6 alkoxy group,

a C1 to C6 alkylthio group, a C1 to C6 alkylsulfinyl group, a C1 to C6 alkylsulfonyl group,

an amino group, a mono (C1 to C6 alkyl) amino group, a di (C1 to C6 alkyl) amino group,

a C1 to C6 acylamino group,

a formyl group, a C2 to C6 acyl group,

a C1 to C6 alkoxycarbonyl group,

a C6 to C10 aryl group which may have one or more substituents, or

a heterocyclic group which may have one or more substituents, wherein the said heterocyclic group is a 5- to 10-membered heterocyclic group having 1 to 9 carbon atoms and 1 to 4 heteroatoms selected independently from a nitrogen atom, an oxygen atom and a sulfur atom, or two adjacent substituents of Y 1 and Y 2 , Y 2 and Y 3 , or Y 3 and Y 4 , together with carbon atoms to which these substituents are attached, form a 4- to 8-membered carbocyclic ring or a 4- to 8-membered heterocyclic ring having 1 to 4 heteroatoms selected independently from an oxygen atom, a sulfur atom and a nitrogen atom, wherein the said formed ring may have one or more substituents; and

X − is a monovalent anion;

provided that the following cases of (i) to (x) are excluded:

(i) R 1 is a trifluoromethyl group,

R 2 and R 3 are each a methyl group,

Y 1 , Y 2 , Y 3 and Y 4 are each a hydrogen atom, and

X − is Br − ;

(ii) R 1 is a trifluoromethyl group,

R 2 and R 3 are each a methyl group,

Y 1 , Y 2 , Y 3 and Y 4 are each a hydrogen atom, and

X − is I − ;

(iii) R 1 is a trifluoromethyl group,

R 2 and R 3 are each a methyl group,

Y 1 is a hydrogen atom,

Y 2 is a methyl group,

Y 3 is a methyl group,

Y 4 is a hydrogen atom, and

X − is I − ;

(iv) R 1 is a trifluoromethyl group,

R 2 and R 3 are each a methyl group,

Y 1 is a hydrogen atom,

Y 2 is a chlorine atom,

Y 3 is a hydrogen atom,

Y 4 is a hydrogen atom, and

X − is Br − ;

(v) R 1 is a trifluoromethyl group,

R 2 and R 3 are each a methyl group,

Y 1 , Y 2 , Y 3 and Y 4 are each a bromine atom,

X − is Br −

(vi) R 1 is a trifluoromethyl group,

R 2 is a butyl group,

R 3 is a propyl substituted by a SO 3 H group,

Y 1 , Y 2 , Y 3 and Y 4 are each a hydrogen atom and

X − is H 2 PO 4 − ;

(vii) R 1 is a trifluoromethyl group,

R 2 is a butyl group,

R 3 is a propyl substituted by a SO 3 H group,

Y 1 , Y 2 , Y 3 and Y 4 are each a hydrogen atom and

X − is HSO 4 − ;

(viii) R 1 is a trifluoromethyl group,

R 2 is a butyl group,

R 3 is a propyl substituted by a SO 3 H group,

Y 1 , Y 2 , Y 3 and Y 4 are each a hydrogen atom and

X − is p-tosylate;

(ix) R 1 is a trifluoromethyl group,

R 2 is a methyl group,

R 3 is a CH═CH—COCF 3 ,

Y 1 , Y 2 , Y 3 and Y 4 are each a hydrogen atom and

X − is triflate; and

(x) R 1 is CH 2 F,

R 2 is a methyl group,

R 3 is an ethyl group,

Y 1 , Y 3 and Y 4 are each a hydrogen atom,

Y 2 is CF 3 and

X − is p-tosylate;

wherein, the one or more substituents in each case is independently selected from the group consisting of a halogen atom, a nitro group, a cyano group,

a C1 to C6 alkyl group,

a C2 to C6 alkenyl group,

a C2 to C6 alkynyl group,

a C3 to C8 cycloalkyl group,

a C1 to C6 haloalkyl group,

a hydroxy group,

a C1 to C6 alkoxy group,

a C1 to C6 haloalkoxy group,

a C1 to C6 alkylthio group, a C1 to C6 alkylsulfinyl group, a C1 to C6 alkylsulfonyl group,

a C1 to C6 haloalkylthio group, a C1 to C6 haloalkylsulfinyl group, a C1 to C6 haloalkylsulfonyl group,

an amino group, a mono (C1 to C6 alkyl) amino group, a di (C1 to C6 alkyl) amino group,

a C1 to C6 acylamino group,

a formyl group, a C2 to C6 acyl group,

a C1 to C6 alkoxycarbonyl group,

a mono (C1 to C6 alkyl) aminocarbonyl group, a di (C1 to C6 alkyl) aminocarbonyl group,

a C6 to C10 aryl group,

a C6 to C10 aryloxy group,

a C6 to C10 aryl C1 to C4 alkyl group, and

a heterocyclic group, wherein the heterocyclic group is a 5- to 10-membered heterocyclic group having 1 to 9 carbon atoms and 1 to 4 heteroatoms selected independently from a nitrogen atom,

an oxygen atom and a sulfur atom.

6. The compound according to claim 5 , wherein

R 1 is a C1 to C4 perfluoroalkyl group;

R 2 and R 3 are each independently a C1 to C4 alkyl group or a phenyl group;

Y 1 , Y 2 , Y 3 and Y 4 are each independently

a hydrogen atom, a halogen atom, a nitro group, a cyano group,

a C1 to C4 alkyl group or a C1 to C4 haloalkyl group; and

X − is Cl − , Br − , I − ,

BF 4 − ,

CF 3 SO 3 − ,

HOSO 3 − , CH 3 OSO 3 − or C 2 H 5 OSO 3 − .

7. The compound according to claim 5 , wherein

R 1 is a trifluoromethyl group or a pentafluoroethyl group;

R 2 and R 3 are each independently a methyl group, an ethyl group or a phenyl group;

Y 1 , Y 2 , Y 3 and Y 4 are each independently a hydrogen atom, a chlorine atom or a nitro group; and

X − is Cl − , Br − , I − ,

BF 4 − ,

CF 3 SO 3 − ,

HOSO 3 − , CH 3 OSO 3 − or C 2 H 5 OSO 3 − .

8. The compound according to claim 5 , wherein

R 1 is a trifluoromethyl group;

R 2 and R 3 are each a methyl group;

Y 1 , Y 2 , Y 3 and Y 4 are each a hydrogen atom; and

X − is CH 3 OSO 3 − .

Assignments (2)
MERGER Recorded Aug 22, 2017
From: IHARA CHEMICAL INDUSTRY CO., LTD.
To: KUMIAI CHEMICAL INDUSTRY CO., LTD.
Reel/Frame 043636/0741 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 15, 2016
From: KAWAZOE, KENTARO; YOSHIOKA, KOTARO
To: IHARA CHEMICAL INDUSTRY CO., LTD.; KUMIAI CHEMICAL INDUSTRY CO., LTD.
Reel/Frame 040983/0932 →
Priority Claims (1)
JP 2014-131688 · Jun 26, 2014 · national
Continuity (1)
Related Publication 20170197920A1 · Jul 13, 2017